Atlas Trials

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

Clinical trial NCT02770391 · COMPLETED

Trial details

NCT number
NCT02770391
Sponsor
Case Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-10-17
Primary completion
2020-04-29
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.